Leading Financial Services and Technology Insights Firms Merge to Form Aite-Novarica Group
Boston, MA, July 21, 2021 (GLOBE NEWSWIRE) -- Aite Group LLC and Novarica Inc. have joined forces to create the leading advisory firm focused on helping executives from banks, payments providers, insurers, securities firms and their respective service providers respond to important technology, market, operations, and regulatory changes.
“We have a tremendous opportunity to leverage our subject-matter experts’ hundreds of years of collective industry experience to advise financial services executives on their most critical decisions,” said Kurt Reisenberg, a former Corporate Executive Board (CEB) executive who is the new CEO of the combined company.
“Our entire team is looking forward to bringing additional insights from adjacent financial services verticals and specialized areas such as fraud, anti-money laundering, and cybersecurity to our insurer CIO clients,” said Matthew Josefowicz, former CEO of Novarica and head of Research Councils for Aite-Novarica Group.
“We are excited about providing new depths of technology leadership experience and advisory capabilities to all of our clients, and about having more impact on decision-makers in the insurance industry,” said Sang Lee, former managing partner of Aite Group and head of Products and Strategy for Aite-Novarica Group.
The combined company offers:
- More than 70 analysts and industry practitioners based in North America and Europe with extensive expertise across all subsectors of the financial services industry
- A library of more than 3,000 reports covering the last 16 years of financial services technology innovations
- Insights drawn from deep relationships with hundreds of banks, payments providers, insurers, and securities firms
- A rapidly growing portfolio of virtual and in-person conferences that provide insights and opportunities to network with peers
- An executive advisory business based on deep relationships with hundreds of Chief Information and Technology Officers
- Detailed analysis of leading vendors across nearly every financial services vertical
The respective firms will continue to maintain their own separate web presences and research libraries through the end of 2021 at https://aitegroup.com andhttps://novarica.com.
For more information about Aite-Novarica Group, please visit us at https://aite-novarica.comor send your inquiry into info@aite-novarica.com.
About Aite-Novarica Group:
Aite-Novarica Group is an advisory firm providing mission-critical insights on technology, regulations, strategy, and operations to hundreds of banks, insurers, payments providers, and investment firms—as well as the technology and service providers that support them. Comprising former senior technology, strategy, and operations executives as well as experienced researchers and consultants, our experts provide actionable advice to our client base, leveraging deep insights developed via our extensive network of clients and other industry contacts.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Adevinta (ASA) publishes its 2023 Annual Report26.4.2024 08:30:00 CEST | Press release
Oslo, 26 April 2024 – Adevinta ASA today released its 2023 Annual Report, available here. A printed copy may be obtained free of charge upon written request to: ir@adevinta.com. Reflecting on 2023, Antoine Jouteau, CEO, said: “Over the past year, we have made significant progress on redesigning our operating model, verticalising our organisation in line with our Growing At Scale strategy and successfully completing our portfolio optimisation. We have achieved strong financial and operational performance in 2023 and continued to deliver against our targets, despite the tough macroeconomic environment. Following the divestment of our Hungarian classifieds business, our portfolio is now centred around our core European markets of France, Germany, Spain, Italy and Benelux, complemented by Canada and our joint ventures. We are delivering significant growth in our Mobility, Re-Commerce and Real Estate & Emerging verticals, substantiating our focus in these areas. By putting technology and pr
PCI Biotech Holding ASA - Annual Report 202326.4.2024 08:08:19 CEST | Press release
Oslo, Norway, April 26, 2024. The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as well as the report according to the European Single Electronic Format (ESEF). The Annual Report 2023 is also available on the company’s website www.pcibiotech.com. For further information, please contact: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CEO, rs@pcibiotech.no, Mobile: +47 940 05 757 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachments 2023 Annual Report PCI Biotech Holding ASApcibiotechholdingasa-2023-12-31-en
Delårsrapport för januari – mars 202426.4.2024 08:00:00 CEST | Pressemelding
STOCKHOLM – den 26 april 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) publicerar idag sin delårsrapport för januari – mars 2024. Den fulla rapporten är tillgänglig på bolagets hemsida. ”Det har varit en stark inledning på 2024 där utvecklingen inom respektive portföljbolag löper enligt plan. Trots att vi haft ett motigt marknadsklimat har våra portföljbolag outtröttligt fortsatt driva utvecklingen av framtidens behandlingar vidare för att de så snabbt som möjligt ska komma patienterna till gagn. Vi ser fram emot tilltagande medvind och fler framsteg under året”, säger Viktor Drvota, VD, Karolinska Development. Väsentliga händelser under första kvartalet Portföljbolaget OssDsign rapporterade positiva data från den kliniska studien TOP FUSION. Top-line-resultaten, som granskats av oberoende radiologer, visar en fusionsgrad på 93 procent 12 månader efter operation med det nya nanosyntetiska bengraftet OssDsign Catalyst (januari 2024).Portföljbolaget AnaCardio erhöll SEK 50 mil
Interim Report - January-March 202426.4.2024 08:00:00 CEST | Press release
STOCKHOLM – 26 April 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report - January-March 2024. The full report is available on the Company's website. “2024 has begun strongly with development within the respective portfolio companies proceeding according to plan. The adverse market climate we have previously experienced notwithstanding, our portfolio companies have continued tirelessly to advance the development of tomorrow’s treatments in order that patients can reap the benefits as quickly as possible. We look forward to an increasing tailwind and further progress during the year”, says Viktor Drvota, CEO, Karolinska Development. Significant events during the first quarter The portfolio company OssDsign reported positive data from the clinical study TOP FUSION. Top-line results show a 93% spinal fusion rate at 12 months as assessed with CT by independent radiological review after surgery with the novel nanosynthetic bone graft OssDsign Catalyst
Solvay publishes notice of 2024 Annual General Meeting26.4.2024 08:00:00 CEST | Press release
Brussels, April 26, 2024, 8:00am CEST - regulated information Solvay today published materials for its next Ordinary General Shareholders’ Meeting, which will be held on Tuesday May 28, 2024 at the Event Lounge Conference Center, Boulevard Général Wahis 16/F, 1030 Brussels, at 10.30 am CEST. All documents relating to this meeting are now available on www.solvay.com. Shareholders will be asked to vote on a number of resolutions, among others: the approval of the financial statements for the financial year 2023; the approval of a total gross dividend of €2.43 per share; the approval of the revised directors’ remuneration; the renewal of the mandate, for a four-year period, of Ms Aude Thibaut de Maisières, as Director of the company; the appointment of EY regarding the assurance of sustainability information imposed by the EU Directive on sustainability reporting (Corporate Sustainability Reporting Directive); the approval of the change of control provision relating to the issuance of eur